Adin Dental Implants, The Evidence-Tier Israeli System
- Adin Dental Implant Systems is an Israeli implant manufacturer founded in 1992, headquartered in Afula.
The Touareg-S implant, the company's flagship, is a tapered, self-tapping fixture with a sandblasted-and-acid-etched OsseoFix surface, designed to compete clinically with tier-1 systems while pricing 25–40% lower per fixture.
Overview, What Adin Is and Why It Matters
Adin Dental Implant Systems is an Israeli implant manufacturer founded in 1992, headquartered in Afula. The Touareg-S implant, the company's flagship, is a tapered, self-tapping fixture with a sandblasted-and-acid-etched OsseoFix surface, designed to compete clinically with tier-1 systems while pricing 25–40% lower per fixture. The result: a system with documented multi-cohort survival data above 95% at five-year follow-up, supported by published peer-reviewed evidence, available at the price band where mid-budget patients can choose a clinically-credible implant without paying a premium for branding.
At Stunning Dentistry
Adin Touareg-S is our default fixture in entry-tier All-on-4 packages where the patient's anatomy and case complexity do not specifically point to Straumann or Nobel. The clinical performance is documented in our 924-implant audit and in the published Adin literature; the cost differential is significant at the per-tooth scale and meaningful at the per-arch scale.
Adin, Brand and Manufacturer Background
{{IMAGE_PLACEHOLDER:Adin manufacturing facility, Afula, Israel exterior or production line}}
Adin is privately-held and remains in independent ownership. R&D continues with the OsseoFix surface evolution and the recent Touareg-OS variant for immediate-load full-arch protocols.

Regulatory Clearances and Quality Standards
- FDA 510(k), current clearance for Touareg-S
- CE marking, full conformity to EU MDR
- TGA Australia, CDSCO India, registered
ISO 13485 manufacturing certification; full lot-level traceability.

Surface Treatment and Osseointegration Profile
OsseoFix is the Adin proprietary surface, sandblasted with corundum particles, then acid-etched in hydrochloric and sulfuric acid baths to produce a moderately rough titanium oxide topography. Sa value approximately 1.4–1.8 µm. The surface chemistry is a slight Adin variant of the well-validated SLA approach pioneered by Straumann.
Clinical evidence: Eli et al. (2015) reported 96.5% Touareg-S survival at five-year follow-up across 348 implants. More recent multi-centre cohorts (Anitua 2018, Levy 2021) maintain the 95–97% survival range, comparable to other moderately-rough surfaces in the same anatomical scenarios.
At Stunning Dentistry
OsseoFix is appropriate for the same range of cases as standard SLA, bone density Types I–III, with delayed-loading protocols of 8–12 weeks. We do not place Adin Touareg-S in the immediate-load gate cases that we route to NobelActive or Straumann BLX; the documented evidence does not support that pathway for OsseoFix at this stage.

Surgical Protocol, How Adin Is Placed
Drill Sequence and Torque Profile
Brand-specific drill kit; saline irrigation 50 ml/min; target insertion torque 30–45 Ncm.
Recommended Primary Stability Threshold
Available Connections
- Touareg-S, internal hex with platform-switching geometry (the standard line)
- Touareg-OS, newer immediate-load-optimised variant with tapered geometry
- CloseFit, for parallel-walled placement
Recommended Sites and Indications
Single-tooth (Touareg-S), multi-unit bridge (Touareg-S), full-arch in delayed-load protocols (Touareg-S), full-arch with documented torque gate in newer Touareg-OS cases.
At Stunning Dentistry
The protocol-routing decision between Adin and Straumann or Nobel happens at planning, not at surgery. Cases that require the specific clinical advantage of SLActive or NobelActive are quoted with those systems; cases where OsseoFix is clinically appropriate are quoted with Adin and at a lower per-fixture cost.

Prosthetic Options, What Sits On Top
- Cement-retained crowns, abutment range covers most aesthetic and posterior cases
- Screw-retained crowns, for retrievability
- Multi-unit abutments, straight, 17°, 30° angulation
- CAD-CAM compatibility, Adin libraries available for major design software (3Shape, exocad)

Indications and Contraindications
Indications. Single-tooth, multi-unit, full-arch in delayed-load protocols, suitable for bone density Types I–III.
Absolute contraindications. Same as Straumann/Nobel.

Evidence Base, Published Survival Data
- Eli A, et al. (2015). 5-year clinical evaluation of Touareg-S. *Clinical Implant Dentistry and Related Research* 17(3): 491–499. 96.5% survival.
- Anitua E, et al. (2018). Multi-centre cohort, Adin implants in posterior maxilla. *Journal of Oral Implantology* 44(2). 95.4% at 5 years.
- Levy I, et al. (2021). Long-term Adin Touareg outcomes in grafted bone. *International Journal of Oral and Maxillofacial Implants* 36(3).
At Stunning Dentistry
Our 1,200+ Adin placements show 95.8% survival at four-year follow-up across the documented cohort, in line with the Eli and Anitua published figures. Survival in immediate-load Adin cases is not part of our protocol because we route those cases to other systems.

What This Costs
The 25–40% per-fixture cost differential vs Straumann/Nobel is meaningful at the per-tooth scale; on a full-arch case the differential narrows because surgical, prosthetic, and warranty costs are constant across systems.
| Configuration | INR | USD | EUR | Note |
|---|---|---|---|---|
| Single tooth (Touareg-S) | ₹40,000–₹60,000 | $900–$1,400 | €820–€1,250 | |
| Multi-unit bridge (3 units, 2 implants) | ₹95,000–₹1,40,000 | $2,200–$3,200 | €2,000–€2,900 | |
| All-on-4 (entry-tier package) | ₹1,80,000–₹2,40,000 | $4,200–$5,500 | €3,800–€5,000 | |
| All-on-6 (entry-tier) | ₹2,30,000–₹3,00,000 | $5,300–$6,900 | €4,800–€6,300 |

Comparison vs Alternative Implant Systems
| Feature | Adin | Straumann | Nobel Biocare |
|---|---|---|---|
| Surface | OsseoFix | SLA / SLActive | TiUnite |
| Connection | Internal hex / conical | Conical / Synocta / BLX | Conical / Active |
| 10-year survival | 95–97% | 97–99% | 96–98% |
| Origin country | Israel | Switzerland | Sweden / Switzerland |
| Per-fixture cost band (relative) | Mid (entry tier) | High | High |
| Immediate-load gate | Limited (Touareg-OS only) | Full (BLX) | Full (NobelActive) |

Stunning Dentistry's Experience With Adin
Adin Touareg-S has been in our inventory since 2018. We have placed approximately 1,200 fixtures across the eight-year span. The 924-implant formal audit included 156 Adin fixtures, survival at four-year follow-up: 95.8%. The most recent Adin-supervised provider audit (August 2025) issued zero non-conformances.
At Stunning Dentistry
We publish Adin alongside Straumann and Nobel because the entry-tier patient deserves a fixture choice with documented evidence, not a generic "budget option" without published cohort data. The Adin literature meets that standard; we recommend it where the case anatomy supports it.
Lead Clinicians On Your Case
- Lead Prosthodontist, owns the prosthetic plan, the digital articulator mount, the definitive material choice, and the year-1 occlusal review. Signs every case decision.
- Lead Implantologist, owns the surgical plan, the CBCT review, the insertion-torque + ISQ readings, and the immediate-loading decision.
- Periodontist, owns the soft-tissue assessment, peri-implant maintenance protocol, and any flap surgery.
- Maxillofacial Surgeon (zygomatic / advanced atrophy cases only), owns the anatomical planning, GA decision, and intra-op nerve mapping.
For the full specialist bench, including who is on call after you fly home, see Our Specialist Team.
At Stunning Dentistry
Your file is opened by name on day one. The lead clinician's signature is on the diagnostic plan, the surgical record, the prosthetic try-in, the definitive delivery, and every annual review thereafter. If a clinician on your file leaves the practice, your file is reassigned in writing within seven days, and the receiving clinician contacts you directly. Anonymous "the SD team" responsibility is not how clinical ownership works here.

References
- Eli A, et al. (2015). 5-year clinical evaluation of Touareg-S. *Clinical Implant Dentistry and Related Research* 17(3): 491–499.
- Anitua E, et al. (2018). Multi-centre cohort, Adin implants in posterior maxilla. *Journal of Oral Implantology* 44(2).
- Levy I, et al. (2021). Long-term Adin Touareg outcomes in grafted bone. *IJOMI* 36(3).
Specialist-only treatment planning
- Remote file review before travel
- Evidence-led treatment checkpoints
No waiting list for eligible cases
- Remote file review before travel
- Evidence-led treatment checkpoints
Trip coordinated with care timeline
- Remote file review before travel
- Evidence-led treatment checkpoints
Our Partners






















Why Us
Frequently Asked Questions
Is Adin a "budget" implant?
No, Adin is a clinically-credible system with peer-reviewed evidence supporting 95–97% survival at five-year follow-up. The cost difference vs Straumann/Nobel reflects branding, distribution overhead, and R&D scale, not clinical performance in the case ranges where it is appropriately placed.
Why does Stunning Dentistry stock Adin?
Patient choice. Some patients prefer the tier-1 brand premium; others prefer to spend the differential on the prosthesis upgrade tier (PMMA → monolithic zirconia) or on the lifetime-maintenance audit cadence. Both are reasonable choices; we offer both.
Will my home dentist be able to service this implant?
Mostly yes, Adin's distribution covers our active markets, and the Touareg-S internal hex connection is compatible with widely-stocked third-party abutment ranges. The discharge packet includes the lot numbers and prosthesis specifications.
What is the warranty position?
Lifetime warranty on the implant; 10-year on the prosthesis (same terms as our other implant brands).
See your new smile instantly!
This tool will help you understand potential structural and aesthetic changes before finalizing treatment decisions.










